ArticleCell biology and toxicology2026
Nanoplastic toxicity and uptake in kidney cells: differential effects of concentration, particle size, and polymer type.
Article in Cell biology and toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Acid-Responsive Nanocarriers for Site-Specific Osteoclast Inhibition and Osteoporosis Therapy: A Review.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Nanoplastics (NPs, < 1 µm) are emerging environmental contaminants capable of crossing biological barriers and interacting at the cellular and subcellular level. Despite evidence of microplastics in human kidney tissue and urine, the renal effects of NPs remain poorly understood. This study investigated the short-term effects of NPs polymer type, size, and concentration on human kidney proximal tubule cells (HK-2). Cells were exposed for 24-h to carboxylated polystyrene (PS), poly(methyl methacrylate) (PMMA), and polyethylene (PE) NPs (15-100 nm) at concentrations from 0.1 to 200 µg/mL. NPs morphology, size, and charge were characterised by scanning electron microscopy, dynamic light scattering, and zeta potential. Cell morphology, viability, cell cycle distribution, and NPs internalisation were assessed by microscopy and flow cytometry. Low-concentration exposures had minimal effects, whereas 100 and 200 µg/mL induced marked morphological changes, including cytoplasmic granularity. Viability decreased significantly at 200 µg/mL for several NPs types, with PE NPs causing the largest reduction (79.4%). Polymer type influenced outcomes, with PE and PMMA NPs causing greater morphological disruption than PS. Size effects were most evident in cell cycle analysis: 15 nm and 20 nm PS NPs and 100 nm PMMA NPs induced phase arrest without major viability loss. NPs internalisation increased with concentration but varied with polymer type, with PE NPs showing preferential perinuclear localisation. These findings demonstrate that NPs effects on kidney cells depend on polymer chemistry, particle size, concentration, and highlight the need for long-term studies using environmentally relevant NPs to better assess kidney toxicity risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.